Atezolizumab plus Bevacizumab in Unresectable Hepatocellular Carcinoma

Richard S. Finn,Shukui Qin,Masafumi Ikeda,Peter R. Galle,Michel Ducreux,Tae-You Kim,Masatoshi Kudo,V V Breder,Philippe Merle,Ahmed Omar Kaseb,Daneng Li,Wendy Verret,Derek-Zhen Xu,Sairy Hernandez,Juan Liu,Chen Huang,Sohail Mulla,Yulei Wang,Ho Yeong Lim,Andrew X. Zhu,Ann-Lii Cheng

Atezolizumab plus Bevacizumab in Unresectable Hepatocellular Carcinoma

2020

Abstract Background The combination of atezolizumab and bevacizumab showed encouraging antitumor activity and safety in a phase 1b trial involving patients with unresectable hepatocellular carcinom...

Keywords:

Oncology
Hepatocellular carcinoma
antitumor activity
Internal medicine
Diabetes mellitus
Medicine
Atezolizumab
Surgery
Bevacizumab
Carcinoma

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

1077

Citations